Dyno Therapeutics has formed a new research partnership with Roche, focusing on the development of next-generation ...

This year, Dyno Nobel is celebrating the 60th anniversary of the construction of its Cheyenne facility, one of 32 across the ...

After forming a gene therapy partnership with Dyno Therapeutics in 2020, Roche is back for more. | In a new deal potentially ...

George Church-founded Dyno Therapeutics Inc. is adding to its list of pharma deals by signing a second research collaboration ...

Privately held Dyno Therapeutics Inc. has added another notch to its adeno-associated virus (AAV) vectors development ...

Roche Holding AG is willing to pay more than $1 billion to solve one of the biggest challenges of gene therapy: delivery.The ...

With an upfront payment of $50 million from Roche, the partnership will leverage Dyno Therapeutics’ in vivo gene therapy ...

Roche has inked a new deal with Dyno Therapeutics to develop next-generation AAV capsids for gene therapies targeting ...

New strategic partnership leverages the power of Dyno’s platform, enabling Roche to advance next-generation AAV gene therapies across multiple targets ...

Roche will use Dyno’s technology, through which Dyno applies AI and high-throughput in vivo data collection to engineering ...

US artificial intelligence (AI) to gene therapy focussed biotech Dyno Therapeutics today announced its second research ...

Explosives and blasting company Dyno Nobel has been going for 180 years, but it now has its sights set on the future of the ...